What is the market price of generic dabrafenib?

Dabrafenib is a BRAF inhibitor that is used to treat a variety of solid tumors carrying BRAF V600E or V600K mutations. It is one of the typical representatives in the era of precision medicine. The drug was initially approved for the treatment of patients with unresectable or metastatic melanoma. As research progresses, its indications have been gradually expanded, including combination with the MEK inhibitor trametinib for BRAF-mutated non-small cell lung cancer, thyroid cancer, etc.

Dabrafenib selectively inhibits the mutated BRAF protein, thereby blocking the MAPK signaling pathway and effectively inhibiting the proliferation and metastasis of tumor cells. The original drug was developed by Novartis and has been launched in China, the United States, Europe, Japan and other countries and regions. The two most common sizes in the Chinese market are 50 mg and 75 mg. The treatment cycle is long and the economic burden is heavy. In order to meet the medication needs of a wider range of patients, generic versions of dabrafenib have appeared in many countries and regions. For example, the generic specifications launched by Laos Daxiong Pharmaceutical, Lucius Pharmaceutical and other manufacturers have passed multiple quality inspection certifications.

Taking the specification75 mg × 120 tablets as an example, the selling price of overseas generic drugs is generally between 2,000 and 3,000 yuan, which has a clear price advantage over original drugs. It should be noted that although generic drugs are highly consistent in ingredients and mechanism of action, there are still certain differences in preparation technology, bioavailability and stability. Therefore, it is recommended that patients purchase drugs through formal channels to avoid encountering inferior products. Currently, there are no domestic generics of dabrafenib that have been officially approved for marketing, and import and use must be done through cross-border medical care, patient assistance programs and other channels. In terms of drug economy and accessibility, generic drugs provide patients with more choices, which is particularly important in situations where there are indications outside of medical insurance or self-pay treatment.

Reference materials:https://go.drugbank.com/drugs/DB08912